- Trials with a EudraCT protocol (217)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
217 result(s) found for: Prevalence rate.
Displaying page 1 of 11.
EudraCT Number: 2019-002762-12 | Sponsor Protocol Number: SJ-674 | Start Date*: 2021-12-07 |
Sponsor Name:Zealand University Hospital | ||
Full Title: The prevalence of bile acid diarrhéa and the effect of budesonid on the bile acid homeostasis in patients with microscopic colitis | ||
Medical condition: Microscopic colitis Bile acid diarrhea | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-000535-23 | Sponsor Protocol Number: HCB/2021/0060 | Start Date*: 2022-06-20 | |||||||||||
Sponsor Name:Barcelona Institute for Global Health (ISGlobal) | |||||||||||||
Full Title: Efficacy of low dose acetylsalicylic acid in preventing adverse maternal and perinatal outcomes in SARS-CoV-2 infected pregnant women | |||||||||||||
Medical condition: SARS-CoV-2 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001587-29 | Sponsor Protocol Number: 02/04/2020-001 | Start Date*: 2020-04-08 | |||||||||||
Sponsor Name:Barcelona Institute for Global Health (ISGlobal) | |||||||||||||
Full Title: Hydroxychloroquine efficacy in preventing SARS-CoV-2 infection and CoVid-19 disease severity during pregnancy | |||||||||||||
Medical condition: SARS-SoV-2 infection and CoVid-19 disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000379-14 | Sponsor Protocol Number: APC009 | Start Date*: 2006-04-07 |
Sponsor Name:Alimentary Health Ltd | ||
Full Title: A double-blind randomised placebo controlled feeding study to establish the effect of a probiotic strain on the course of Clostridium difficile carriage in humans. | ||
Medical condition: Clostridium difficile infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000228-33 | Sponsor Protocol Number: CE/17-12-06 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:CHU Saint-Pierre | |||||||||||||
Full Title: Prospective longitudinal study on immunogenicity, induction of cellular immune responses and safety of vaccination against HPV with the 9valent vaccine in HIV-positive women | |||||||||||||
Medical condition: Immune responses to administration of 9valent vaccine against HPV in HIV-positive women | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001124-20 | Sponsor Protocol Number: PCOS-5 | Start Date*: 2005-04-18 |
Sponsor Name:Sigrun Kjøtrød | ||
Full Title: Metformin treatment before IVF/ICSI in normal weight women with polycystic ovarian syndrome. A European, prospective, randomised, double blind, multicenter study. | ||
Medical condition: Polycystic ovary syndrome (PCOS) is a disorder characterized by polycystic ovaries, oligo-amenorrhea and hyperandrogenism. It is the most common endocrine disorder in women of fertile age. PCOS wom... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DK (Completed) SE (Completed) FI (Completed) GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000761-37 | Sponsor Protocol Number: A3051073 | Start Date*: 2018-03-23 | |||||||||||
Sponsor Name:Pfizer, Inc. | |||||||||||||
Full Title: A Twelve-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study With Follow-up Evaluating The Safety And Efficacy Of Varenicline For Smoking Cessation In Healthy Ado... | |||||||||||||
Medical condition: NICOTINE DEPENDENCE | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004879-36 | Sponsor Protocol Number: 100450 | Start Date*: 2015-05-22 |
Sponsor Name:GlaxoSmithKline Biologicals | ||
Full Title: Comparative study of the immunogenicity and protective efficacy of GlaxoSmithKline Biologicals’ rec-DNA Hepatitis B vaccine (10µg) with or without Hepatitis B immunoglobulin (HBIG) in newborns of H... | ||
Medical condition: Vaccination of healthy newborns of HBsAg+ and/or HBeAg+ mothers against Hepatitis. | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2011-002629-23 | Sponsor Protocol Number: 100449 | Start Date*: 2015-05-22 |
Sponsor Name:GlaxoSmithKline Biologicals | ||
Full Title: Immunogenicity and protective efficacy of GlaxoSmithKline Biologicals’ rec-Hepatitis B vaccine (10 µg) in newborns of Hepa-titis B envelope antigen positive (HBeAg+) and Hepatitis B surface antigen... | ||
Medical condition: Hepatitis B vaccination in healthy newborns of HBeAg+ and HBsAg+ mothers | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2005-004486-42 | Sponsor Protocol Number: CaVenT | Start Date*: 2006-01-03 |
Sponsor Name:Eastern Norway Regional Health Authority
[...]
1. Eastern Norway Regional Health Authority
2. Ullevaal University Hospital |
||
Full Title: Catheter-directed Venous Thrombolysis (CaVenT) in Acute Iliofemoral Vein Thrombosis - an open Randomized, Controlled, Clinical Trial | ||
Medical condition: Acute ilio-femoral vein thrombosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-001045-21 | Sponsor Protocol Number: FSD-MIC-2022-03 | Start Date*: 2023-04-10 |
Sponsor Name:FUNDACION SANTIAGO DEXEUS FONT | ||
Full Title: A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of two formulations of vaginal micronized progesterone. | ||
Medical condition: Infertility | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-000607-42 | Sponsor Protocol Number: KN-1/06 | Start Date*: 2006-02-20 |
Sponsor Name:Institute for clinical and experimental Medicine | ||
Full Title: Treatment of borderline changesin protocol biopsy 3 months after renal transplantation | ||
Medical condition: Patients with transplanted kidney and stabilised graft function | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003670-40 | Sponsor Protocol Number: PAN.1 | Start Date*: 2018-04-05 |
Sponsor Name:Beatrix Children's Hospital, University Medical Center Groningen | ||
Full Title: Pediatric Ards Neuromuscular blockade (PAN) study: Life-threatening acute respiratory failure in children: to breathe or not to breathe spontaneously, that's the question. | ||
Medical condition: Pediatric Acute Respiratory Distress Syndrome necessitating mechanical ventilation | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000610-38 | Sponsor Protocol Number: CPDR001J2201 | Start Date*: 2018-10-19 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A randomized, open-label, phase II open platform study evaluating the efficacy and safety of novel spartalizumab (PDR001) combinations in previously treated unresectable or metastatic melanoma | |||||||||||||
Medical condition: Unresectable or metastatic melanoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) FR (Prematurely Ended) DE (Prematurely Ended) NL (Prematurely Ended) ES (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003972-11 | Sponsor Protocol Number: NEPAFOX | Start Date*: 2014-05-13 | ||||||||||||||||
Sponsor Name:Institut für Klinisch-Onkologische Forschung Krankenhaus Nordwest GmbH | ||||||||||||||||||
Full Title: Randomized multicenter phase II/III study with adjuvant gemcitabine versus neoadjuvant/adjuvant FOLFIRINOX in resectable pancreatic cancer | ||||||||||||||||||
Medical condition: resectable adenocarcinoma of the pancreas | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-000546-31 | Sponsor Protocol Number: A3051104 | Start Date*: 2008-07-16 | |||||||||||
Sponsor Name:Pfizer Ltd, Ramsgate Road,Sandwich,Kent CT13 9NJ | |||||||||||||
Full Title: A RANDOMIZED, MULTICENTRE, DOUBLE BLIND, PLACEBO CONTROLLED STUDY EVALUATING THE EFFICACY OF VARENICLINE IN CESSATION OF ORAL TOBACCO USE | |||||||||||||
Medical condition: Cessation of oral smokeless tobacco use in current non-smokers. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004518-40 | Sponsor Protocol Number: PCV13-HIV2011 | Start Date*: 2011-10-25 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA SENESE | |||||||||||||
Full Title: Serological response to antipneumococcal vaccination and consequent impact on Streptococcus pneumoniae nasal carriage in HIV positive adults: a prospective study using 13-valent conjugate vaccine | |||||||||||||
Medical condition: HIV positive adults with out previous PPV23 or PCV7 vaccination | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-004894-25 | Sponsor Protocol Number: ATCC10AA_IS_ICDJ10-J18 | Start Date*: 2009-06-30 |
Sponsor Name:Karolinska University Hospital Huddinge | ||
Full Title: Effect of rosuvastatin on cardiovascular events and mortality after pneumonia | ||
Medical condition: Community aquired pneumonia | ||
Disease: | ||
Population Age: | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004901-29 | Sponsor Protocol Number: NBK154/1/2020 | Start Date*: 2021-06-01 | |||||||||||
Sponsor Name:Medical University of Gdańsk | |||||||||||||
Full Title: The efficacy and safety of Metoprolol as add-on treatment to standard of care in preventing cardiomyopathy in patients with Duchenne Muscular Dystrophy aged 8-17 years. A randomized, double-blind, ... | |||||||||||||
Medical condition: Duchenne muscular dystrophy Cardiomyopathy Tachycardia | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male | ||||||||||||
Trial protocol: PL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002852-19 | Sponsor Protocol Number: BO42533 | Start Date*: 2021-03-10 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: A PHASE II, RANDOMIZED, DOUBLE-BLIND STUDY OF ATEZOLIZUMAB PLUS TIRAGOLUMAB AND ATEZOLIZUMAB PLUS PLACEBO AS FIRST-LINE TREATMENT IN PATIENTS WITH RECURRENT/METASTATIC PD-L1 POSITIVE SQUAMOUS CELL ... | |||||||||||||
Medical condition: Squamous cell carcinoma of the head and neck (SCCHN). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) PL (Trial now transitioned) HU (Trial now transitioned) CZ (Trial now transitioned) IT (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
